Genesis IBRC India Ltd
Fundamental Score
Genesis IBRC India Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of GENESIS across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Return on Equity (51.62%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (51.62%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Excellent EPS Growth (105.89% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (105.89% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
6 factors identified
Profit Decline Concern (-101.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Negative Free Cash Flow (₹-0.33 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (11.33%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Genesis IBRC India Ltd
About GENESIS
Business Overview
Genesis IBRC India Limited does not have significant operations. The company was previously engaged in the manufacture and marketing of pro-biotic products for aquaculture, agriculture, poultry, and animal husbandry markets in India. The company was formerly known as SSK Lifestyles Limited. Genesis IBRC India Limited was incorporated in 1992 and is based in Eluru, India.
Company Details
Key Leadership
Latest News
GENESIS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Genesis IBRC India Ltd (GENESIS)?
As of 29 Jan 2026, 10:32 am IST, Genesis IBRC India Ltd (GENESIS) is currently trading at ₹86.10. The stock has a market capitalization of ₹177.38 (Cr).
Is GENESIS share price Overvalued or Undervalued?
GENESIS is currently trading at a P/E ratio of 0.00x, compared to the industry average of 51.82x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Genesis IBRC India Ltd share price?
Key factors influencing GENESIS's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Genesis IBRC India Ltd a good stock for long-term investment?
Genesis IBRC India Ltd shows a 5-year Profit Growth of 105.89% and an ROE of 51.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Genesis IBRC India Ltd compare with its industry peers?
Genesis IBRC India Ltd competes with major peers in the Biotechnology. Investors should compare GENESIS's P/E of 0.00x and ROE of 51.62% against the industry averages to determine its competitive standing.
What is the P/E ratio of GENESIS and what does it mean?
GENESIS has a P/E ratio of N/Ax compared to the industry average of 51.82x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is GENESIS performing according to Bull Run's analysis?
GENESIS has a Bull Run fundamental score of 25/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does GENESIS belong to?
GENESIS operates in the Biotechnology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Genesis IBRC India Ltd.
What is Return on Equity (ROE) and why is it important for GENESIS?
GENESIS has an ROE of 51.62%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Genesis IBRC India Ltd generates profits from shareholders' equity.
How is GENESIS's debt-to-equity ratio and what does it indicate?
GENESIS has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is GENESIS's dividend yield and is it a good dividend stock?
GENESIS offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has GENESIS grown over the past 5 years?
GENESIS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 105.89%, and EPS Growth 105.89%.
What is the promoter holding in GENESIS and why does it matter?
Promoters hold 11.33% of GENESIS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is GENESIS's market capitalization category?
GENESIS has a market capitalization of ₹177 crores, placing it in the Small-cap category.
How volatile is GENESIS stock?
GENESIS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for GENESIS?
GENESIS has a 52-week high of ₹N/A and low of ₹N/A.
What is GENESIS's operating profit margin trend?
GENESIS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is GENESIS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of -101.64%.
What is the institutional holding pattern in GENESIS?
GENESIS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.